P1287: HETROMBOPAG FOR ENHANCEMENT OF PLATELET ENGRAFTMENT IN PATIENTS WITH LYMPHOMA AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION

P1287: HETROMBOPAG FOR ENHANCEMENT OF PLATELET ENGRAFTMENT IN PATIENTS WITH LYMPHOMA AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION

Bibliographic Details
Main Authors:	Linjun Zhao, Lingyan Ping, Shaoxuan Hu, Honghong Ding, Xiaopei Wang, Yuqin Song, Jun Zhu, Weiping Liu
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000972036.34899.e5

Similar Items

Effect of autologous hematopoietic stem cell transplantation for patients with peripheral T-cell lymphoma in China: A propensity score-matched analysis
by: Hongye Gao, et al.
Published: (2022-11-01)

Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma
by: Chen Zhang, et al.
Published: (2023-05-01)

Assessment of Platelet Activation and Immature Platelet Fraction as Predictors of Platelet Engraftment after Hematopoietic Stem Cell Transplantation
by: Tang-Her Jaing M.D., et al.
Published: (2016-07-01)

Autologous Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Lymphoma
by: Babak Bahar, et al.
Published: (2012-07-01)

Autologous Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Lymphoma
by: Fatemeh Ghaffari, et al.
Published: (2012-09-01)

Autologous hematopoietic stem cell transplantation in classical Hodgkin's lymphoma
by: Afonso José Pereira Cortez, et al.
Published: (2011-02-01)

Autologous hematopoietic stem cell transplant in pediatric lymphoma our experience
by: Pranoti Chiwarkar, et al.
Published: (2022-01-01)

Association between CRP Level on Admission Day and Length of Hospitalization and Engraftment in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
by: Farzaneh Tavakoli, et al.
Published: (2021-08-01)

Autologous Hematopoietic Stem Cell Transplantation for Patients with Lymphoma-Associated Hemophagocytic lymphohistiocytosis
by: Yue Song, et al.
Published: (2021-11-01)

Utility of Procalcitonin in the Engraftment Phase of Hematopoietic Stem Cell Transplantation in Children
by: Koray Yalçın, et al.
Published: (2022-09-01)

PB2449: EFFECT OF MOBILIZATION METHODS ON CD34+ AND TOTAL NUCLEATED CELL COUNT AND THEIR RELATION WITH ENGRAFTMENT IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Ozlem Beyler, et al.
Published: (2023-08-01)

The role of T helper 22 cells during engraftment at hematopoietic stem cell transplantation
by: O. Yucel, et al.
Published: (2020-10-01)

CLINICAL EFFECTS OF MESENCHYMAL STROMAL CELLS IN LYMPHOMA PATIENTS WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: E. V. Batorov, et al.
Published: (2012-05-01)

Clinical practice optimization exploration and future prospects of autologous hematopoietic stem cell transplantation for lymphoma
by: JIN Zhengming
Published: (2022-02-01)

Homing and Engraftment of Hematopoietic Stem Cells Following Transplantation: A Pre-Clinical Perspective
by: Tanvir Hasan, et al.
Published: (2024-01-01)

Infectious complications during pre-engraftment after allogeneic hematopoietic stem cell transplantation
by: Rima Moghnieh, et al.
Published: (2020-12-01)

Clinical Characteristics, Microbiology, and Risk Factors for Mortality of Pre-Engraftment and Post-Engraftment Bloodstream Infection in Hematopoietic Stem Cell Transplantation Recipients
by: Chen W, et al.
Published: (2022-11-01)

Decreased circulating myeloid-derived suppressor cell count at the engraftment is one of the risk factors for multiple myeloma relapse after autologous hematopoietic stem cell transplantation
by: Tamara Tyrinova, et al.
Published: (2024-03-01)

Clinical Efficacy and Prognostic Factors of Autologous Hematopoietic Stem Cell Transplantation for Hodgkin's Lymphoma in 38 Cases
by: HUANG Zhenghua, et al.
Published: (2022-09-01)

Autologous hematopoietic stem cell transplantation for systemic scleroderma
by: R T Alekperov, et al.
Published: (2012-08-01)

Is post-transplant day + 14 immature reticulocyte fraction (IRF) a reliable surrogate marker for predicting early platelet engraftment in pediatric hematopoietic stem cell transplant?
by: Zainab Ghias, et al.
Published: (2023-02-01)

Outcome of Acute Respiratory Failure Secondary to Engraftment in Children After Hematopoietic Stem Cell Transplant
by: Lama Elbahlawan, et al.
Published: (2020-10-01)

Quickly attainable and highly engrafting hematopoietic stem cells
by: Hal E. Broxmeyer
Published: (2019-08-01)

Retracted: “Factors Affecting Time to Engraftment During Autologous Stem Cell Transplantation in Patients With Multiple Myeloma”
Published: (2023-08-01)

RETRACTED: Factors Affecting Time to Engraftment During Autologous Stem Cell Transplantation in Patients With Multiple Myeloma
by: Ali Z. Bolaman, et al.
Published: (2021-09-01)

The influence of cell concentration at cryopreservation on neutrophil engraftment after autologous peripheral blood stem cell transplantation
by: Olga Margareth Wanderley de Oliveira Félix, et al.
Published: (2018-07-01)

Autologous Peripheral Blood Stem Cell Transplantation Among Lymphoproliferative Disease Patients: Factors Influencing Engraftment
by: Mohd Nazri Hassan, et al.
Published: (2019-05-01)

Autologous Peripheral Blood Stem Cell Transplantation Among Lymphoproliferative Disease Patients: Factors Influencing Engraftment
by: Mohd Nazri Hassan, et al.
Published: (2019-01-01)

High dose melphalan is an adequate preparative regimen for autologous hematopoietic stem cell transplantation in relapsed/refractory lymphoma
by: José A. Fernández-Gutiérrez, et al.
Published: (2022-12-01)

The association of disease type, pre-transplant hemoglobin level and platelet count with transfusion requirement after autologous hematopoietic stem cell transplantation
by: Shabnam Tabasi, et al.
Published: (2021-09-01)

Effects of anti-HLA donor-specific antibodies and desensitization on engraftment of haploidentical hematopoietic stem cell transplantation
by: MA Yao, et al.
Published: (2024-02-01)

Autologous hematopoietic stem cell transplantation for refractory Crohn's disease
by: Antonio Giordano, et al.
Published: (2022-10-01)

Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis
by: Nicoletta Del Papa, et al.
Published: (2018-10-01)

Autologous transplant: microbial contamination of hematopoietic stem cell products
by: Igor Dullius Almeida, et al.

SHIPi Enhances Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
by: Sandra Fernandes, et al.
Published: (2015-03-01)

Optimizing autologous hematopoietic stem cell transplantation for acute leukemia
by: Aiming Pang, et al.
Published: (2021-11-01)

Herpes zoster after autologous hematopoietic stem cell transplantation
by: Kelli Borges dos Santos, et al.

Hemophagocytic Lymphohistiocytosis (HLH): A Rare Cause of Primary Engraftment Failure Post Autologous Stem Cell Transplant
by: Pallavi Mehta, et al.
Published: (2023-07-01)

Efficacy of CEAC regimen before autologous hematopoietic stem cell transplantation for non-Hodgkin lymphoma: analysis of 102 cases
by: YANG Yichun, et al.
Published: (2019-12-01)

Brazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for malignant lymphomas
by: Bruno Kosa Lino Duarte, et al.
Published: (2011-12-01)